Status:
COMPLETED
Therapies for Treatment-Resistant Panic Disorder Symptoms
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Panic Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
This study will determine the effectiveness of different treatments for panic disorder symptoms in individuals who still have symptoms after initial treatment with medication.
Detailed Description
Panic disorder is a serious condition that may cause significant psychological and physical distress. Many patients with panic disorder remain symptomatic despite initial intervention. Unfortunately, ...
Eligibility Criteria
Inclusion
- Diagnosis of panic disorder
Exclusion
- History of bipolar disorder, schizophrenia, psychosis, or delusional disorders
- Post-traumatic stress disorder diagnosis within 6 months prior to study entry
- Current use of psychotropic medications
- Current use of cognitive behavioral therapy
Key Trial Info
Start Date :
March 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00118417
Start Date
March 1 1999
End Date
October 1 2007
Last Update
June 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114